Mersana Therapeutics, Inc.（MRSN）内部人交易：高管与董事近期交易
过去 18 个月，共有 13 位内部人为 Mersana Therapeutics, Inc.（MRSN）报告了 22 笔 Form 4 交易（最近一笔 2026-01-06）。
| 日期 | 内部人 | 职务 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-01-06 | Protopapas Anna | 董事 | 卖出 | 6,721 | $0 |
| 2026-01-06 | Protopapas Anna | 董事 | 卖出 | 2,890 | $0 |
| 2026-01-06 | Protopapas Anna | 董事 | 卖出 | 9,609 | $0 |
| 2026-01-06 | Mandelia Ashish | VP, Chief Accounting Officer | 卖出 | 2,300 | $0 |
| 2026-01-06 | Hege Kristen | 董事 | 卖出 | 578 | $0 |
| 2026-01-06 | MOTT DAVID M | 董事 | 卖出 | 23,546 | $0 |
| 2026-01-06 | MOTT DAVID M | 董事 | 卖出 | 383 | $0 |
| 2026-01-06 | Huber Martin H. Jr. | President, CEO | 卖出 | 9,573 | $0 |
| 2026-01-06 | Hack Andrew A. F. | 董事 | 卖出 | 578 | $0 |
| 2026-01-06 | Hack Andrew A. F. | 董事 | 卖出 | 346,545 | $0 |
| 2026-01-06 | Carvajal Alejandra | SVP, Chief Legal Officer | 卖出 | 3,131 | $0 |
| 2026-01-06 | Lowinger Timothy B | SVP, Chief Sci.&Tech. Officer | 卖出 | 10,466 | $0 |
| 2026-01-06 | Bala Mohan | SVP, Chief Development | 卖出 | 2,927 | $0 |
| 2026-01-06 | Dere Willard H | 董事 | 卖出 | 1,567 | $0 |
| 2026-01-06 | Diaz Allene M. | 董事 | 卖出 | 578 | $0 |
| 2026-01-06 | DeSchuytner Brian | SVP, COO & CFO | 卖出 | 5,015 | $0 |
| 2026-01-06 | Alleva Lawrence M | 董事 | 卖出 | 578 | $0 |
| 2026-01-06 | Alleva Lawrence M | 董事 | 卖出 | 84 | $0 |
| 2025-10-28 | Bala Mohan | SVP, Chief Development Officer | 买入 | 250 | $0 |
| 2025-10-28 | Bala Mohan | SVP, Chief Development Officer | 卖出 | 77 | $762 |
| 2025-09-15 | Huber Martin H. Jr. | President, CEO | 买入 | 6,670 | $0 |
| 2025-09-15 | Huber Martin H. Jr. | President, CEO | 卖出 | 2,012 | $14,708 |
来源：SEC Form 4 申报文件 · 截至 2026-01-06